Literature DB >> 379883

Paroxysmal EEG activity and psychopathology during the treatment with clozapine.

M Koukkou, J Angst, D Zimmer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 379883     DOI： 10.1055/s-0028-1094608

Source DB:  PubMed          Journal:  Pharmakopsychiatr Neuropsychopharmakol        ISSN： 0031-7098


× No keyword cloud information.
  10 in total

1.  Efficacy and adverse effects of clozapine in the treatment of schizophrenia and tardive dyskinesia--a retrospective study of 387 patients.

Authors:  D Naber; M Leppig; R Grohmann; H Hippius
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

Review 2.  Predictors and markers of clozapine response.

Authors:  Carmen Chung; Gary Remington
Journal:  Psychopharmacology (Berl)       Date:  2005-02-17       Impact factor: 4.530

Review 3.  Clinical experience with clozapine in Germany.

Authors:  H Helmchen
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

Review 4.  A review of evidence for GABergic predominance/glutamatergic deficit as a common etiological factor in both schizophrenia and affective psychoses: more support for a continuum hypothesis of "functional" psychosis.

Authors:  R F Squires; E Saederup
Journal:  Neurochem Res       Date:  1991-10       Impact factor: 3.996

5.  EEG alterations in patients treated with clozapine in relation to plasma levels.

Authors:  C Haring; C Neudorfer; J Schwitzer; M Hummer; A Saria; H Hinterhuber; W W Fleischhacker
Journal:  Psychopharmacology (Berl)       Date:  1994-02       Impact factor: 4.530

Review 6.  Adverse effects of antipsychotic drugs.

Authors:  A K Malhotra; R E Litman; D Pickar
Journal:  Drug Saf       Date:  1993-12       Impact factor: 5.606

7.  Seroquel (ICI 204 636), a putative "atypical" antipsychotic, in schizophrenia with positive symptomatology: results of an open clinical trial and changes of neuroendocrinological and EEG parameters.

Authors:  H Wetzel; A Szegedi; C Hain; J Wiesner; S Schlegel; O Benkert
Journal:  Psychopharmacology (Berl)       Date:  1995-05       Impact factor: 4.530

8.  Clozapine serum levels and side effects during steady state treatment of schizophrenic patients: a cross-sectional study.

Authors:  O V Olesen; K Thomsen; P N Jensen; C H Wulff; N A Rasmussen; C Refshammer; J Sørensen; M Bysted; J Christensen; R Rosenberg
Journal:  Psychopharmacology (Berl)       Date:  1995-02       Impact factor: 4.530

Review 9.  Clozapine versus typical neuroleptic medication for schizophrenia.

Authors:  Adib Essali; Nahla Al-Haj Haasan; Chunbo Li; John Rathbone
Journal:  Cochrane Database Syst Rev       Date:  2009-01-21

10.  Myoclonic epileptic seizures during clozapine treatment: a report of three cases.

Authors:  E Gouzoulis; H Grunze; U von Bardeleben
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1991       Impact factor: 5.270
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.